Theranostic radiopharmaceuticals, which combine diagnosis and therapy within a single administration, are transforming the management of cancer and other diseases. T...
AbbVie recently announced that the European Commission (EC) has granted conditional marketing authorization for TEPKINLY® (epcoritamab) as a monotherapy for the treatment...
A virtual marketplace leading your business into the future
